1887

Journal of Medical Microbiology logo

Volume 61, Issue 9

Current concepts on the virulence mechanisms of meticillin-resistant Free

Abstract

Meticillin-resistant (MRSA) strains are prevalent bacterial pathogens that cause both health care and community-associated infections. Increasing resistance to commonly prescribed antibiotics has made MRSA a serious threat to public health throughout the world. The USA300 strain of MRSA has been responsible for an epidemic of community-associated infections in the US, mostly involving skin and soft tissue but also more serious invasive syndromes such as pneumonia, severe sepsis and endocarditis. MRSA strains are particularly serious and potentially lethal pathogens that possess virulence mechanisms including toxins, adhesins, enzymes and immunomodulators. One of these is Panton–Valentine leukocidin (PVL), a toxin associated with abscess formation and severe necrotizing pneumonia. Earlier studies suggested that PVL was a major virulence factor in community-associated MRSA infections. However, some recent data have not supported this association while others have, leading to controversy. Therefore, investigators continue to search for additional mechanisms of pathogenesis. In this review, we summarize the current understanding of the biological basis of MRSA virulence and explore future directions for research, including potential vaccines and antivirulence therapies under development that might allow clinicians to more successfully treat and prevent MRSA infections.

  • Published Online:
© 2012 SGM
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.043513-0
2012-09-01
2024-04-18
Loading full text...

Full text loading...

/deliver/fulltext/jmm/61/9/1179.html?itemId=/content/journal/jmm/10.1099/jmm.0.043513-0&mimeType=html&fmt=ahah

References

  1. Aparecida Guimarães M., Coelho L. R., Souza R. R., Ferreira-Carvalho B. T., Sá Figueiredo A. M. 2011; The impact of biocides on biofilm formation by methicillin-resistant Staphylococcus aureus (ST239-SCCmecIII) isolates. Microbiol Immunol 56:203–207[PubMed] [CrossRef]
     [Google Scholar]
  2. Aslam S., Darouiche R. O. 2011; Role of antibiofilm-antimicrobial agents in controlling device-related infections. Int J Artif Organs 34:752–758 [View Article][PubMed]
     [Google Scholar]
  3. Baddour L. M., Wilson W. R., Bayer A. S., Fowler V. G. Jr, Bolger A. F., Levison M. E., Ferrieri P., Gerber M. A., Tani L. Y. other authors 2005; Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111:e394–e434 [View Article][PubMed]
     [Google Scholar]
  4. Bae I. G., Tonthat G. T., Stryjewski M. E., Rude T. H., Reilly L. F., Barriere S. L., Genter F. C., Corey G. R., Fowler V. G. Jr 2009; Presence of genes encoding the Panton-Valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinational trial. J Clin Microbiol 47:3952–3957 [View Article][PubMed]
     [Google Scholar]
  5. Bartels M. D., Hansen L. H., Boye K., Sørensen S. J., Westh H. 2011; An unexpected location of the arginine catabolic mobile element (ACME) in a USA300-related MRSA strain. PLoS ONE 6:e16193 [View Article][PubMed]
     [Google Scholar]
  6. Bassetti M., Trecarichi E. M., Mesini A., Spanu T., Giacobbe D. R., Rossi M., Shenone E., Pascale G. D., Molinari M. P. other authors 2011; Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia. Clin Microbiol Infect http://dx.doi.org/10.1111/j.1469-0691.2011.03679.x[PubMed]
     [Google Scholar]
  7. Beenken K. E., Mrak L. N., Griffin L. M., Zielinska A. K., Shaw L. N., Rice K. C., Horswill A. R., Bayles K. W., Smeltzer M. S. 2010; Epistatic relationships between sarA and agr in Staphylococcus aureus biofilm formation. PLoS ONE 5:e10790 [View Article][PubMed]
     [Google Scholar]
  8. Bernardo K., Pakulat N., Fleer S., Schnaith A., Utermöhlen O., Krut O., Müller S., Krönke M. 2004; Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression. Antimicrob Agents Chemother 48:546–555 [View Article][PubMed]
     [Google Scholar]
  9. Bisdorff B., Scholhölter J. L., Claußen K., Pulz M., Nowak D., Radon K. 2011; MRSA-ST398 in livestock farmers and neighbouring residents in a rural area in Germany. Epidemiol Infect [View Article] http://dx.doi.org/10.1017/S0950268811002378
     [Google Scholar]
  10. Boakes E., Kearns A. M., Ganner M., Perry C., Hill R. L., Ellington M. J. 2011; Distinct bacteriophages encoding Panton-Valentine leukocidin (PVL) among international methicillin-resistant Staphylococcus aureus clones harboring PVL. J Clin Microbiol 49:684–692 [View Article][PubMed]
     [Google Scholar]
  11. Boles B. R., Horswill A. R. 2008; Agr-mediated dispersal of Staphylococcus aureus biofilms. PLoS Pathog 4:e1000052 [View Article][PubMed]
     [Google Scholar]
  12. Bordi C., de Bentzmann S. 2011; Hacking into bacterial biofilms: a new therapeutic challenge. Ann Intensive Care 1:19 [View Article][PubMed]
     [Google Scholar]
  13. Brown M. L., O’Hara F. P., Close N. M., Mera R. M., Miller L. A., Suaya J. A., Amrine-Madsen H. 2012; Prevalence and sequence variation of Panton-Valentine leukocidin in methicillin-resistant Staphylococcus aureus strains in the United States. J Clin Microbiol 50:86–90 [View Article][PubMed]
     [Google Scholar]
  14. Bubeck Wardenburg J., Bae T., Otto M., DeLeo F. R., Schneewind O. 2007; Poring over pores: α-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 13:1405–1406 [View Article][PubMed]
     [Google Scholar]
  15. Bubeck Wardenburg J., Palazzolo-Ballance A. M., Otto M., Schneewind O., DeLeo F. R. 2008; Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. J Infect Dis 198:1166–1170 [View Article][PubMed]
     [Google Scholar]
  16. Burdette S. D., Watkins R. R., Wong K. K., Mathew S. D., Martin D. J., Markert R. J. 2012; Staphylococcus aureus pyomyositis compared with non-Staphylococcus aureus pyomyositis. J Infect 64:507–512 [View Article][PubMed]
     [Google Scholar]
  17. Cameron D. R., Howden B. P., Peleg A. Y. 2011; The interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomes. Clin Infect Dis 53:576–582 [View Article][PubMed]
     [Google Scholar]
  18. Capparelli R., Nocerino N., Medaglia C., Blaiotta G., Bonelli P., Iannelli D. 2011; The Staphylococcus aureus peptidoglycan protects mice against the pathogen and eradicates experimentally induced infection. PLoS ONE 6:e28377 [CrossRef]
     [Google Scholar]
  19. Changchien C. H., Chen Y. Y., Chen S. W., Chen W. L., Tsay J. G., Chu C. 2011; Retrospective study of necrotizing fasciitis and characterization of its associated methicillin-resistant Staphylococcus aureus in Taiwan. BMC Infect Dis 11:297 [View Article][PubMed]
     [Google Scholar]
  20. Chatterjee S. S., Chen L., Joo H. S., Cheung G. Y., Kreiswirth B. N., Otto M. 2011; Distribution and regulation of the mobile genetic element-encoded phenol-soluble modulin PSM-mec in methicillin-resistant Staphylococcus aureus . PLoS ONE 6:e28781 [View Article][PubMed]
     [Google Scholar]
  21. Chow O. A., von Köckritz-Blickwede M., Bright A. T., Hensler M. E., Zinkernagel A. S., Cogen A. L., Gallo R. L., Monestier M., Wang Y. other authors 2010; Statins enhance formation of phagocyte extracellular traps. Cell Host Microbe 8:445–454 [View Article][PubMed]
     [Google Scholar]
  22. Chua T., Moore C. L., Perri M. B., Donabedian S. M., Masch W., Vager D., Davis S. L., Lulek K., Zimnicki B., Zervos M. J. 2008; Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit. J Clin Microbiol 46:2345–2352 [View Article][PubMed]
     [Google Scholar]
  23. Collins J., Rudkin J., Recker M., Pozzi C., O’Gara J. P., Massey R. C. 2010; Offsetting virulence and antibiotic resistance costs by MRSA. ISME J 4:577–584 [View Article][PubMed]
     [Google Scholar]
  24. Cosgrove S. E., Sakoulas G., Perencevich E. N., Schwaber M. J., Karchmer A. W., Carmeli Y. 2003; Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36:53–59 [View Article][PubMed]
     [Google Scholar]
  25. Cosgrove S. E., Qi Y., Kaye K. S., Harbarth S., Karchmer A. W., Carmeli Y. 2005; The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 26:166–174 [View Article][PubMed]
     [Google Scholar]
  26. Costello M. E., Huygens F. 2011; Diversity of community acquired MRSA carrying the PVL gene in Queensland and New South Wales, Australia. Eur J Clin Microbiol Infect Dis 30:1163–1167 [View Article][PubMed]
     [Google Scholar]
  27. D’Agata E. M. C., Webb G. F., Horn M. A., Moellering R. C. Jr, Ruan S. 2009; Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals. Clin Infect Dis 48:274–284 [View Article][PubMed]
     [Google Scholar]
  28. Daum R. S., Spellberg B. 2012; Progress toward a Staphylococcus aureus vaccine. Clin Infect Dis 54:560–567 [View Article][PubMed]
     [Google Scholar]
  29. David M. Z., Daum R. S. 2010; Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 23:616–687 [View Article][PubMed]
     [Google Scholar]
  30. De Angelis G., Francois P., Lee A., Schrenzel J., Renzi G., Girard M., Pittet D., Harbarth S. 2011; Molecular and epidemiological evaluation of strain replacement in patients previously harboring gentamicin-resistant MRSA. J Clin Microbiol 49:3880–3884 [CrossRef]
     [Google Scholar]
  31. Diep B. A., Gill S. R., Chang R. F., Phan T. H., Chen J. H., Davidson M. G., Lin F., Lin J., Carleton H. A. other authors 2006; Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus . Lancet 367:731–739 [View Article][PubMed]
     [Google Scholar]
  32. Diep B. A., Palazzolo-Ballance A. M., Tattevin P., Basuino L., Braughton K. R., Whitney A. R., Chen L., Kreiswirth B. N., Otto M. other authors 2008; Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. PLoS ONE 3:e3198 [View Article][PubMed]
     [Google Scholar]
  33. Diep B. A., Chan L., Tattevin P., Kajikawa O., Martin T. R., Basuino L., Mai T. T., Marbach H., Braughton K. R. other authors 2010; Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci U S A 107:5587–5592 [View Article][PubMed]
     [Google Scholar]
  34. Drago L., De Vecchi E., Nicola L., Gismondo M. R. 2007; In vitro evaluation of antibiotics’ combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections. BMC Infect Dis 7:111 [View Article][PubMed]
     [Google Scholar]
  35. Dulon M., Haamann F., Peters C., Schablon A., Nienhaus A. 2011; MRSA prevalence in European healthcare settings: a review. BMC Infect Dis 11:138 [View Article][PubMed]
     [Google Scholar]
  36. Dumitrescu O., Boisset S., Badiou C., Bes M., Benito Y., Reverdy M. E., Vandenesch F., Etienne J., Lina G. 2007; Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin. Antimicrob Agents Chemother 51:1515–1519 [View Article][PubMed]
     [Google Scholar]
  37. Dumitrescu O., Tristan A., Meugnier H., Bes M., Gouy M., Etienne J., Lina G., Vandenesch F. 2008; Polymorphism of the Staphylococcus aureus Panton-Valentine leukocidin genes and its possible link with the fitness of community-associated methicillin-resistant S. aureus . J Infect Dis 198:792–794 [View Article][PubMed]
     [Google Scholar]
  38. Dumitrescu O., Choudhury P., Boisset S., Badiou C., Bes M., Benito Y., Wolz C., Vandenesch F., Etienne J. other authors 2011; Beta-lactams interfering with PBP1 induce Panton-Valentine leukocidin expression by triggering sarA and rot global regulators of Staphylococcus aureus . Antimicrob Agents Chemother 55:3261–3271 [View Article][PubMed]
     [Google Scholar]
  39. Durand G., Bes M., Meugnier H., Enright M. C., Forey F., Liassine N., Wenger A., Kikuchi K., Lina G. other authors 2006; Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France. J Clin Microbiol 44:847–853 [View Article][PubMed]
     [Google Scholar]
  40. Ellis M. W., Griffith M. E., Jorgensen J. H., Hospenthal D. R., Mende K., Patterson J. E. 2009; Presence and molecular epidemiology of virulence factors in methicillin-resistant Staphylococcus aureus strains colonizing and infecting soldiers. J Clin Microbiol 47:940–945 [View Article][PubMed]
     [Google Scholar]
  41. Etz H., Minh D. B., Henics T., Dryla A., Winkler B., Triska C., Boyd A. P., Söllner J., Schmidt W. other authors 2002; Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus . Proc Natl Acad Sci U S A 99:6573–6578 [View Article][PubMed]
     [Google Scholar]
  42. Foster T. J., Höök M. 1998; Surface protein adhesins of Staphylococcus aureus . Trends Microbiol 6:484–488 [View Article][PubMed]
     [Google Scholar]
  43. Francis J. S., Doherty M. C., Lopatin U., Johnston C. P., Sinha G., Ross T., Cai M., Hansel N. N., Perl T. other authors 2005; Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 40:100–107 [View Article][PubMed]
     [Google Scholar]
  44. Genestier A. L., Michallet M. C., Prévost G., Bellot G., Chalabreysse L., Peyrol S., Thivolet F., Etienne J., Lina G. other authors 2005; Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J Clin Invest 115:3117–3127 [View Article][PubMed]
     [Google Scholar]
  45. George E. A., Novick R. P., Muir T. W. 2008; Cyclic peptide inhibitors of staphylococcal virulence prepared by Fmoc-based thiolactone peptide synthesis. J Am Chem Soc 130:4914–4924 [View Article][PubMed]
     [Google Scholar]
  46. Gillet Y., Issartel B., Vanhems P., Fournet J. C., Lina G., Bes M., Vandenesch F., Piémont Y., Brousse N. other authors 2002; Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359:753–759 [View Article][PubMed]
     [Google Scholar]
  47. Gordon R. J., Lowy F. D. 2008; Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 46:Suppl. 5S350–S359 [View Article][PubMed]
     [Google Scholar]
  48. Gould I. M., David M. Z., Esposito S., Garau J., Lina G., Mazzei T., Peters G. 2012; New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance. Int J Antimicrob Agents 39:96–104 [View Article][PubMed]
     [Google Scholar]
  49. Hermos C. R., Yoong P., Pier G. B. 2010; High levels of antibody to panton-valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft-tissue infection. Clin Infect Dis 51:1138–1146 [View Article][PubMed]
     [Google Scholar]
  50. Hidron A. I., Edwards J. R., Patel J., Horan T. C., Sievert D. M., Pollock D. A., Fridkin S. K. for the National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities 2008; NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007.. Infect Control Hosp Epidemiol 29:996–1011 [View Article][PubMed]
     [Google Scholar]
  51. Hongo I., Baba T., Oishi K., Morimoto Y., Ito T., Hiramatsu K. 2009; Phenol-soluble modulin alpha 3 enhances the human neutrophil lysis mediated by Panton-Valentine leukocidin. J Infect Dis 200:715–723 [View Article][PubMed]
     [Google Scholar]
  52. Hu D. L., Maina E. K., Omoe K., Inoue F., Yasujima M., Nakane A. 2011; Superantigenic toxin genes coexist with specific staphylococcal cassette chromosome mec genes in methicillin-resistant Staphylococcus aureus . Tohoku J Exp Med 225:161–169 [View Article][PubMed]
     [Google Scholar]
  53. Inoshima I., Inoshima N., Wilke G. A., Powers M. E., Frank K. M., Wang Y., Bubeck Wardenburg J. 2011; A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice. Nat Med 17:1310–1314 [View Article][PubMed]
     [Google Scholar]
  54. Iwao Y., Takano T., Higuchi W., Yamamoto T. 2011; A new staphylococcal cassette chromosome mec IV encoding a novel cell-wall-anchored surface protein in a major ST8 community-acquired methicillin-resistant Staphylococcus aureus clone in Japan. J Infect Chemother 18:96–104[PubMed] [CrossRef]
     [Google Scholar]
  55. Izano E. A., Amarante M. A., Kher W. B., Kaplan J. B. 2008; Differential roles of poly-N-acetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofilms. Appl Environ Microbiol 74:470–476 [View Article][PubMed]
     [Google Scholar]
  56. Jiménez J. N., Ocampo A. M., Vanegas J. M., Rodríguez E. A., Garcés C. G., Patiño L. A., Ospina S., Correa M. M. 2011; Characterisation of virulence genes in methicillin susceptible and resistant Staphylococcus aureus isolates from a paediatric population in a university hospital of Medellín, Colombia. Mem Inst Oswaldo Cruz 106:980–985[PubMed] [CrossRef]
     [Google Scholar]
  57. Joo H. S., Cheung G. Y., Otto M. 2011; Antimicrobial activity of community-associated methicillin-resistant Staphylococcus aureus is caused by phenol-soluble modulin derivatives. J Biol Chem 286:8933–8940 [View Article][PubMed]
     [Google Scholar]
  58. Joshi G. S., Spontak J. S., Klapper D. G., Richardson A. R. 2011; Arginine catabolic mobile element encoded speG abrogates the unique hypersensitivity of Staphylococcus aureus to exogenous polyamines. Mol Microbiol 82:9–20 [CrossRef]
     [Google Scholar]
  59. Kaito C., Saito Y., Nagano G., Ikuo M., Omae Y., Hanada Y., Han X., Kuwahara-Arai K., Hishinuma T. other authors 2011; Transcription and translation products of the cytolysin gene psm-mec on the mobile genetic element SCCmec regulate Staphylococcus aureus virulence. PLoS Pathog 7:e1001267 [View Article][PubMed]
     [Google Scholar]
  60. Kateete D. P., Namazzi S., Okee M., Okeng A., Baluku H., Musisi N. L., Katabazi F. A., Joloba M. L., Ssentongo R., Najjuka F. C. 2011; High prevalence of methicillin resistant Staphylococcus aureus in the surgical units of Mulago hospital in Kampala, Uganda. BMC Res Notes 4:326 [View Article][PubMed]
     [Google Scholar]
  61. Kawamura H., Nishi J., Imuta N., Tokuda K., Miyanohara H., Hashiguchi T., Zenmyo M., Yamamoto T., Ijiri K. other authors 2011; Quantitative analysis of biofilm formation of methicillin-resistant Staphylococcus aureus (MRSA) strains from patients with orthopaedic device-related infections. FEMS Immunol Med Microbiol 63:10–15 [View Article][PubMed]
     [Google Scholar]
  62. Kazakova S. V., Hageman J. C., Matava M., Srinivasan A., Phelan L., Garfinkel B., Boo T., McAllister S., Anderson J. other authors 2005; A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 352:468–475 [View Article][PubMed]
     [Google Scholar]
  63. Kechrid A., Pérez-Vázquez M., Smaoui H., Hariga D., Rodríguez-Baños M., Vindel A., Baquero F., Cantón R., Del Campo R. 2011; Molecular analysis of community-acquired methicillin-susceptible and resistant Staphylococcus aureus isolates recovered from bacteraemic and osteomyelitis infections in children from Tunisia. Clin Microbiol Infect 17:1020–1026 [View Article][PubMed]
     [Google Scholar]
  64. Kennedy A. D., Bubeck Wardenburg J., Gardner D. J., Long D., Whitney A. R., Braughton K. R., Schneewind O., DeLeo F. R. 2010; Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J Infect Dis 202:1050–1058 [View Article][PubMed]
     [Google Scholar]
  65. Kiedrowski M. R., Kavanaugh J. S., Malone C. L., Mootz J. M., Voyich J. M., Smeltzer M. S., Bayles K. W., Horswill A. R. 2011; Nuclease modulates biofilm formation in community-associated methicillin-resistant Staphylococcus aureus . PLoS ONE 6:e26714 [View Article][PubMed]
     [Google Scholar]
  66. Kielian T., Cheung A., Hickey W. F. 2001; Diminished virulence of an alpha-toxin mutant of Staphylococcus aureus in experimental brain abscesses. Infect Immun 69:6902–6911 [View Article][PubMed]
     [Google Scholar]
  67. Klevens R. M., Morrison M. A., Nadle J., Petit S., Gershman K., Ray S., Harrison L. H., Lynfield R., Dumyati G. other authors 2007; Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763–1771 [View Article][PubMed]
     [Google Scholar]
  68. Kobayashi S. D., DeLeo F. R. 2009; An update on community-associated MRSA virulence. Curr Opin Pharmacol 9:545–551 [View Article][PubMed]
     [Google Scholar]
  69. Kobayashi S. D., Malachowa N., Whitney A. R., Braughton K. R., Gardner D. J., Long D., Bubeck Wardenburg J., Schneewind O., Otto M., Deleo F. R. 2011; Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J Infect Dis 204:937–941 [View Article][PubMed]
     [Google Scholar]
  70. Kreienbuehl L., Charbonney E., Eggimann P. 2011; Community-acquired necrotizing pneumonia due to methicillin-sensitive Staphylococcus aureus secreting Panton-Valentine leukocidin: a review of case reports. Ann Intensive Care 1:52 [View Article][PubMed]
     [Google Scholar]
  71. Kretschmer D., Gleske A. K., Rautenberg M., Wang R., Köberle M., Bohn E., Schöneberg T., Rabiet M. J., Boulay F., Klebanoff S. J. 2010; Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus . Cell Host Microbe 7:463–473 [View Article][PubMed]
     [Google Scholar]
  72. Labandeira-Rey M., Couzon F., Boisset S., Brown E. L., Bes M., Benito Y., Barbu E. M., Vazquez V., Höök M. other authors 2007; Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 315:1130–1133 [View Article][PubMed]
     [Google Scholar]
  73. Lamy B., Laurent F., Gallon O., Doucet-Populaire F., Etienne J., Decousser J. W. The Collège de Bactériologie Virologie Hygiène (ColBVH) Study Group 2012; Antibacterial resistance, genes encoding toxins and genetic background among Staphylococcus aureus isolated from community-acquired skin and soft tissue infections in France: a national prospective survey. Eur J Clin Microbiol Infect Dis 31:1279–1284[PubMed] [CrossRef]
     [Google Scholar]
  74. LaPlante K. L., Woodmansee S. 2009; Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis. Antimicrob Agents Chemother 53:3880–3886 [View Article][PubMed]
     [Google Scholar]
  75. Lauderdale K. J., Malone C. L., Boles B. R., Morcuende J., Horswill A. R. 2010; Biofilm dispersal of community-associated methicillin-resistant Staphylococcus aureus on orthopedic implant material. J Orthop Res 28:55–61[PubMed]
     [Google Scholar]
  76. Lee S. M., Ender M., Adhikari R., Smith J. M. B., Berger-Bächi B., Cook G. M. 2007; Fitness cost of staphylococcal cassette chromosome mec in methicillin-resistant Staphylococcus aureus by way of continuous culture. Antimicrob Agents Chemother 51:1497–1499 [View Article][PubMed]
     [Google Scholar]
  77. Lescure F.-X., Locher G., Eveillard M., Biendo M., Van Agt S., Le Loup G., Douadi Y., Ganry O., Vandenesch F. other authors 2006; Community-acquired infection with healthcare-associated methicillin-resistant Staphylococcus aureus: the role of home nursing care. Infect Control Hosp Epidemiol 27:1213–1218 [View Article][PubMed]
     [Google Scholar]
  78. Li M., Cheung G. Y., Hu J., Wang D., Joo H. S., Deleo F. R., Otto M. 2010; Comparative analysis of virulence and toxin expression of global community-associated methicillin-resistant Staphylococcus aureus strains. J Infect Dis 202:1866–1876 [View Article][PubMed]
     [Google Scholar]
  79. Li S., Skov R. L., Han X., Larsen A. R., Larsen J., Sørum M., Wulf M., Voss A., Hiramatsu K., Ito T. 2011; Novel types of staphylococcal cassette chromosome mec elements identified in clonal complex 398 methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 55:3046–3050 [View Article][PubMed]
     [Google Scholar]
  80. Lina G., Piémont Y., Godail-Gamot F., Bes M., Peter M. O., Gauduchon V., Vandenesch F., Etienne J. 1999; Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29:1128–1132 [View Article][PubMed]
     [Google Scholar]
  81. Lipinska U., Hermans K., Meulemans L., Dumitrescu O., Badiou C., Duchateau L., Haesebrouck F., Etienne J., Lina G. 2011; Panton-Valentine leukocidin does play a role in the early stage of Staphylococcus aureus skin infections: a rabbit model. PLoS ONE 6:e22864 [View Article][PubMed]
     [Google Scholar]
  82. Liu C. I., Liu G. Y., Song Y., Yin F., Hensler M. E., Jeng W. Y., Nizet V., Wang A. H., Oldfield E. 2008; A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science 319:1391–1394 [View Article][PubMed]
     [Google Scholar]
  83. Liu C., Bayer A., Cosgrove S. E., Daum R. S., Fridkin S. K., Gorwitz R. J., Kaplan S. L., Karchmer A. W., Levine D. P. other authors 2011; Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 52:285–292 [View Article][PubMed]
     [Google Scholar]
  84. Löffler B., Hussain M., Grundmeier M., Brück M., Holzinger D., Varga G., Roth J., Kahl B. C., Proctor R. A., Peters G. 2010; Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog 6:e1000715 [View Article][PubMed]
     [Google Scholar]
  85. Ma X. X., Ito T., Tiensasitorn C., Jamklang M., Chongtrakool P., Boyle-Vavra S., Daum R. S., Hiramatsu K. 2002; Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 46:1147–1152 [View Article][PubMed]
     [Google Scholar]
  86. Ma X., Chang W., Zhang C., Zhou X., Yu F. 2012; Staphylococcal Panton-Valentine leukocidin induces pro-inflammatory cytokine production and nuclear factor-kappa B activation in neutrophils. PLoS ONE 7:e34970 [View Article][PubMed]
     [Google Scholar]
  87. Malachowa N., Whitney A. R., Kobayashi S. D., Sturdevant D. E., Kennedy A. D., Braughton K. R., Shabb D. W., Diep B. A., Chambers H. F. other authors 2011; Global changes in Staphylococcus aureus gene expression in human blood. PLoS ONE 6:e18617 [View Article][PubMed]
     [Google Scholar]
  88. Malcolm B. 2011; The rise of methicillin-resistant Staphylococcus aureus in US correctional populations. J Correct Health Care 17:254–265 [View Article][PubMed]
     [Google Scholar]
  89. Mann E. E., Rice K. C., Boles B. R., Endres J. L., Ranjit D., Chandramohan L., Tsang L. H., Smeltzer M. S., Horswill A. R., Bayles K. W. 2009; Modulation of eDNA release and degradation affects Staphylococcus aureus biofilm maturation. PLoS ONE 4:e5822 [View Article][PubMed]
     [Google Scholar]
  90. Marimón J. M., Villar M., García-Arenzana J. M., Caba I. L., Pérez-Trallero E. 2012; Molecular characterization of Staphylococcus aureus carrying the panton-valentine leucocidin genes in northern Spain. J Infect 64:47–53 [View Article][PubMed]
     [Google Scholar]
  91. Megyeri K., Mándi Y., Degré M., Rosztóczy I. 2002; Induction of cytokine production by different Staphylococcal strains. Cytokine 19:206–212 [View Article][PubMed]
     [Google Scholar]
  92. Merckoll P., Jonassen T. O., Vad M. E., Jeansson S. L., Melby K. K. 2009; Bacteria, biofilm and honey: a study of the effects of honey on ‘planktonic’ and biofilm-embedded chronic wound bacteria. Scand J Infect Dis 41:341–347 [View Article][PubMed]
     [Google Scholar]
  93. Monecke S., Coombs G., Shore A. C., Coleman D. C., Akpaka P., Borg M., Chow H., Ip M., Jatzwauk L. other authors 2011; A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus . PLoS ONE 6:e17936 [View Article][PubMed]
     [Google Scholar]
  94. Montgomery C. P., Daum R. S. 2009; Transcription of inflammatory genes in the lung after infection with community-associated methicillin-resistant Staphylococcus aureus: a role for panton-valentine leukocidin?. Infect Immun 77:2159–2167 [View Article][PubMed]
     [Google Scholar]
  95. Montgomery C. P., Boyle-Vavra S., Adem P. V., Lee J. C., Husain A. N., Clasen J., Daum R. S. 2008; Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. J Infect Dis 198:561–570 [View Article][PubMed]
     [Google Scholar]
  96. Montgomery C. P., Boyle-Vavra S., Daum R. S. 2009; The arginine catabolic mobile element is not associated with enhanced virulence in experimental invasive disease caused by the community-associated methicillin-resistant Staphylococcus aureus USA300 genetic background. Infect Immun 77:2650–2656 [View Article][PubMed]
     [Google Scholar]
  97. Morrison M. A., Hageman J. C., Klevens R. M. 2006; Case definition for community-associated methicillin-resistant Staphylococcus aureus . J Hosp Infect 62:241 [View Article][PubMed]
     [Google Scholar]
  98. O’Hara F. P., Guex N., Word J. M., Miller L. A., Becker J. A., Walsh S. L., Scangarella N. E., West J. M., Shawar R. M., Amrine-Madsen H. 2008; A geographic variant of the Staphylococcus aureus Panton-Valentine leukocidin toxin and the origin of community-associated methicillin-resistant S. aureus USA300. J Infect Dis 197:187–194 [View Article][PubMed]
     [Google Scholar]
  99. Ono H. K., Omoe K., Imanishi K., Iwakabe Y., Hu D. L., Kato H., Saito N., Nakane A., Uchiyama T., Shinagawa K. 2008; Identification and characterization of two novel staphylococcal enterotoxins, types S and T. Infect Immun 76:4999–5005 [View Article][PubMed]
     [Google Scholar]
  100. Otter J. A., French G. L. 2010; Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe. Lancet Infect Dis 10:227–239 [View Article][PubMed]
     [Google Scholar]
  101. Otto M. 2010; Staphylococcus aureus toxin gene hitchhikes on a transferable antibiotic resistance element. Virulence 1:49–51 [View Article][PubMed]
     [Google Scholar]
  102. Patti J. M. 2011; Will we ever see the approval of a Staphylococcus aureus vaccine?. Expert Rev Anti Infect Ther 9:845–846 [View Article][PubMed]
     [Google Scholar]
  103. Peyrani P., Allen M., Wiemken T. L., Haque N. Z., Zervos M. J., Ford K. D., Scerpella E. G., Mangino J. E., Kett D. H., Ramirez J. A. IMPACT-HAP Study Group 2011; Severity of disease and clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus strains not influenced by the presence of the Panton-Valentine Leukocidin gene. Clin Infect Dis 53:766–771 [View Article][PubMed]
     [Google Scholar]
  104. Prabhakara R., Harro J. M., Leid J. G., Harris M., Shirtliff M. E. 2011a; Murine immune response to a chronic Staphylococcus aureus biofilm infection.. Infect Immun 79:1789–1796 [View Article][PubMed]
     [Google Scholar]
  105. Prabhakara R., Harro J. M., Leid J. G., Keegan A. D., Prior M. L., Shirtliff M. E. 2011b; Suppression of the inflammatory immune response prevents the development of chronic biofilm infection due to methicillin-resistant Staphylococcus aureus . Infect Immun 79:5010–5018 [View Article][PubMed]
     [Google Scholar]
  106. Queck S. Y., Khan B. A., Wang R., Bach T. H., Kretschmer D., Chen L., Kreiswirth B. N., Peschel A., Deleo F. R., Otto M. 2009; Mobile genetic element-encoded cytolysin connects virulence to methicillin resistance in MRSA. PLoS Pathog 5:e1000533 [View Article][PubMed]
     [Google Scholar]
  107. Quinn G. A., Cole A. M. 2007; Suppression of innate immunity by a nasal carriage strain of Staphylococcus aureus increases its colonization on nasal epithelium. Immunology 122:80–89 [View Article][PubMed]
     [Google Scholar]
  108. Raad I., Mohamed J. A., Reitzel R. A., Jiang Y., Raad S., Al Shuaibi M., Chaftari A. M., Hachem R. Y. 2012; Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi. Antimicrob Agents Chemother 56:935–941 [View Article][PubMed]
     [Google Scholar]
  109. Rankin S., Roberts S., O’Shea K., Maloney D., Lorenzo M., Benson C. E. 2005; Panton valentine leukocidin (PVL) toxin positive MRSA strains isolated from companion animals. Vet Microbiol 108:145–148 [View Article][PubMed]
     [Google Scholar]
  110. Rasigade J. P., Laurent F., Lina G., Meugnier H., Bes M., Vandenesch F., Etienne J., Tristan A. 2010; Global distribution and evolution of Panton-Valentine leukocidin-positive methicillin-susceptible Staphylococcus aureus, 1981–2007.. J Infect Dis 201:1589–1597 [View Article][PubMed]
     [Google Scholar]
  111. Rigby K. M., DeLeo F. R. 2012; Neutrophils in innate host defense against Staphylococcus aureus infections. Semin Immunopathol 34:237–259 [View Article][PubMed]
     [Google Scholar]
  112. Robert J., Tristan A., Cavalié L., Decousser J. W., Bes M., Etienne J., Laurent F. ONERBA (Observatoire National de l'Epidémiologie de Résistance Bactérienne aux Antibiotiques) 2011; Panton-valentine leukocidin-positive and toxic shock syndrome toxin 1-positive methicillin-resistant Staphylococcus aureus: a French multicenter prospective study in 2008. Antimicrob Agents Chemother 55:1734–1739 [CrossRef]
     [Google Scholar]
  113. Roberts M. C., Soge O. O., No D., Helgeson S. E., Meschke J. S. 2011; Characterization of Methicillin-resistant Staphylococcus aureus isolated from public surfaces on a university campus, student homes and local community. J Appl Microbiol 110:1531–1537 [View Article][PubMed]
     [Google Scholar]
  114. Salem A. H., Elkhatib W. F., Ahmed G. F., Noreddin A. M. 2010; Pharmacodynamics of moxifloxacin versus vancomycin against biofilms of methicillin-resistant Staphylococcus aureus and epidermidis in an in vitro model. J Chemother 22:238–242[PubMed] [CrossRef]
     [Google Scholar]
  115. Sanchini A., Campanile F., Monaco M., Cafiso V., Rasigade J. P., Laurent F., Etienne J., Stefani S., Pantosti A. 2011; DNA microarray-based characterisation of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus from Italy. Eur J Clin Microbiol Infect Dis 30:1399–1408 [View Article][PubMed]
     [Google Scholar]
  116. Schroeder K., Jularic M., Horsburgh S. M., Hirschhausen N., Neumann C., Bertling A., Schulte A., Foster S., Kehrel B. E. other authors 2009; Molecular characterization of a novel Staphylococcus aureus surface protein (SasC) involved in cell aggregation and biofilm accumulation. PLoS ONE 4:e7567 [View Article][PubMed]
     [Google Scholar]
  117. Schubert S., Schwertz H., Weyrich A. S., Franks Z. G., Lindemann S., Otto M., Behr H., Loppnow H., Schlitt A. other authors 2011; Staphylococcus aureus α-toxin triggers the synthesis of B-cell lymphoma 3 by human platelets. Toxins (Basel) 3:120–133[PubMed] [CrossRef]
     [Google Scholar]
  118. Sharma-Kuinkel B. K., Ahn S. H., Rude T. H., Zhang Y., Tong S. Y., Ruffin F., Genter F. C., Braughton K. R., Deleo F. R., Barriere S. L. 2012; Presence of genes encoding Panton Valentine Leukocidin (PVL) is not the primary determinant of outcome in patients with hospital-acquired pneumonia due to Staphylococcus aureus . J Clin Microbiol 50:848–856 [CrossRef]
     [Google Scholar]
  119. Sheen T. R., Cavaco C. K., Ebrahimi C. M., Thoman M. L., Sanderson S. D., Morgan E. L., Doran K. S. 2011; Control of methicillin resistant Staphylococcus aureus infection utilizing a novel immunostimulatory peptide. Vaccine 30:9–13 [View Article][PubMed]
     [Google Scholar]
  120. Shoham M. 2011; Antivirulence agents against MRSA. Future Med Chem 3:775–777 [View Article][PubMed]
     [Google Scholar]
  121. Shore A. C., Rossney A. S., Brennan O. M., Kinnevey P. M., Humphreys H., Sullivan D. J., Goering R. V., Ehricht R., Monecke S., Coleman D. C. 2011; Characterization of a novel arginine catabolic mobile element (ACME) and staphylococcal chromosomal cassette mec composite island with significant homology to Staphylococcus epidermidis ACME type II in methicillin-resistant Staphylococcus aureus genotype ST22-MRSA-IV. Antimicrob Agents Chemother 55:1896–1905 [View Article][PubMed]
     [Google Scholar]
  122. Sing A., Tuschak C., Hörmansdorfer S. 2008; Methicillin-resistant Staphylococcus aureus in a family and its pet cat. N Engl J Med 358:1200–1201 [View Article][PubMed]
     [Google Scholar]
  123. Smith K., Gould K. A., Ramage G., Gemmell C. G., Hinds J., Lang S. 2010; Influence of tigecycline on expression of virulence factors in biofilm-associated cells of methicillin-resistant Staphylococcus aureus . Antimicrob Agents Chemother 54:380–387 [View Article][PubMed]
     [Google Scholar]
  124. Stevens D. L., Ma Y., Salmi D. B., McIndoo E., Wallace R. J., Bryant A. E. 2007; Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus . J Infect Dis 195:202–211 [View Article][PubMed]
     [Google Scholar]
  125. Tan H., Peng Z., Li Q., Xu X., Guo S., Tang T. 2012; The use of quaternised chitosan-loaded PMMA to inhibit biofilm formation and downregulate the virulence-associated gene expression of antibiotic-resistant staphylococcus. Biomaterials 33:365–377 [View Article][PubMed]
     [Google Scholar]
  126. Taylor E., Webster T. J. 2011; Reducing infections through nanotechnology and nanoparticles. Int J Nanomedicine 6:1463–1473[PubMed] [CrossRef]
     [Google Scholar]
  127. Tenover F. C., Goering R. V. 2009; Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J Antimicrob Chemother 64:441–446 [View Article][PubMed]
     [Google Scholar]
  128. Tenover F. C., Tickler I. A., Goering R. V., Kreiswirth B. N., Mediavilla J. R., Persing D. H. MRSA Consortium 2012; Characterization of nasal and blood culture isolates of Methicillin-resistant Staphylococcus aureus from patients in United States Hospitals. Antimicrob Agents Chemother 56:1324–1330 [CrossRef]
     [Google Scholar]
  129. Thomas D., Chou S., Dauwalder O., Lina G. 2007; Diversity in Staphylococcus aureus enterotoxins. Chem Immunol Allergy 93:24–41 [View Article][PubMed]
     [Google Scholar]
  130. Thurlow L. R., Hanke M. L., Fritz T., Angle A., Aldrich A., Williams S. H., Engebretsen I. L., Bayles K. W., Horswill A. R., Kielian T. 2011; Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J Immunol 186:6585–6596 [View Article][PubMed]
     [Google Scholar]
  131. Tkaczyk C., Hua L., Varkey R., Shi Y., Dettinger L., Woods R., Barnes A., Macgill R. S., Wilson S. other authors 2012; Identification of anti-alpha toxin mAbs that reduce severity of Staphylococcus aureus dermonecrosis and exhibit a correlation between affinity and potency. Clin Vaccine Immunol 19:377–385[PubMed] [CrossRef]
     [Google Scholar]
  132. Tristan A., Benito Y., Montserret R., Boisset S., Dusserre E., Penin F., Ruggiero F., Etienne J., Lortat-Jacob H. other authors 2009; The signal peptide of Staphylococcus aureus panton valentine leukocidin LukS component mediates increased adhesion to heparan sulfates. PLoS ONE 4:e5042 [View Article][PubMed]
     [Google Scholar]
  133. Tseng C. W., Kyme P., Low J., Rocha M. A., Alsabeh R., Miller L. G., Otto M., Arditi M., Diep B. A. other authors 2009; Staphylococcus aureus Panton-Valentine leukocidin contributes to inflammation and muscle tissue injury. PLoS ONE 4:e6387 [View Article][PubMed]
     [Google Scholar]
  134. Turabelidze G., Lin M., Wolkoff B., Dodson D., Gladbach S., Zhu B. P. 2006; Personal hygiene and methicillin-resistant Staphylococcus aureus infection. Emerg Infect Dis 12:422–427 [View Article][PubMed]
     [Google Scholar]
  135. van Hal S. J., Lodise T. P., Paterson D. L. 2012; The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis 54:755–771 [View Article][PubMed]
     [Google Scholar]
  136. Varshney A. K., Martinez L. R., Hamilton S. M., Bryant A. E., Levi M. H., Gialanella P., Stevens D. L., Fries B. C. 2010; Augmented production of Panton-Valentine leukocidin toxin in methicillin-resistant and methicillin-susceptible Staphylococcus aureus is associated with worse outcome in a murine skin infection model. J Infect Dis 201:92–96 [View Article][PubMed]
     [Google Scholar]
  137. Voyich J. M., Otto M., Mathema B., Braughton K. R., Whitney A. R., Welty D., Long R. D., Dorward D. W., Gardner D. J. other authors 2006; Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease?. J Infect Dis 194:1761–1770 [View Article][PubMed]
     [Google Scholar]
  138. Wang R., Braughton K. R., Kretschmer D., Bach T. H., Queck S. Y., Li M., Kennedy A. D., Dorward D. W., Klebanoff S. J. other authors 2007; Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 13:1510–1514 [View Article][PubMed]
     [Google Scholar]
  139. Wassenberg M., Kluytmans J., Erdkamp S., Bosboom R., Buiting A., van Elzakker E., Melchers W., Thijsen S., Troelstra A. other authors 2012; Costs and benefits of rapid screening of methicillin-resistant Staphylococcus aureus carriage in intensive care units: a prospective multicenter study. Crit Care 16:R22 [View Article][PubMed]
     [Google Scholar]
  140. Weiss E. C., Zielinska A., Beenken K. E., Spencer H. J., Daily S. J., Smeltzer M. S. 2009; Impact of sarA on daptomycin susceptibility of Staphylococcus aureus biofilms in vivo. Antimicrob Agents Chemother 53:4096–4102 [View Article][PubMed]
     [Google Scholar]
  141. Wilson G. J., Seo K. S., Cartwright R. A., Connelley T., Chuang-Smith O. N., Merriman J. A., Guinane C. M., Park J. Y., Bohach G. A. other authors 2011; A novel core genome-encoded superantigen contributes to lethality of community-associated MRSA necrotizing pneumonia. PLoS Pathog 7:e1002271 [CrossRef]
     [Google Scholar]
  142. Wolter D. J., Tenover F. C., Goering R. V. 2007; Allelic variation in genes encoding Panton-Valentine leukocidin from community-associated Staphylococcus aureus . Clin Microbiol Infect 13:827–830 [View Article][PubMed]
     [Google Scholar]
  143. Wright J. S. III, Jin R., Novick R. P. 2005; Transient interference with staphylococcal quorum sensing blocks abscess formation. Proc Natl Acad Sci U S A 102:1691–1696 [View Article][PubMed]
     [Google Scholar]
  144. Yanagihara K., Araki N., Watanabe S., Kinebuchi T., Kaku M., Maesaki S., Yamaguchi K., Matsumoto T., Mikamo H. other authors 2012; Antimicrobial susceptibility and molecular characteristics of 857 methicillin-resistant Staphylococcus aureus isolates from 16 medical centers in Japan (2008-2009): nationwide survey of community-acquired and nosocomial MRSA. Diagn Microbiol Infect Dis 72:253–257 [View Article][PubMed]
     [Google Scholar]
  145. Zielinska A. K., Beenken K. E., Joo H. S., Mrak L. N., Griffin L. M., Luong T. T., Lee C. Y., Otto M., Shaw L. N., Smeltzer M. S. 2011; Defining the strain-dependent impact of the Staphylococcal accessory regulator (sarA) on the alpha-toxin phenotype of Staphylococcus aureus . J Bacteriol 193:2948–2958 [View Article][PubMed]
     [Google Scholar]
  146. Zivkovic A., Sharif O., Stich K., Doninger B., Biaggio M., Colinge J., Bilban M., Mesteri I., Hazemi P. other authors 2011; TLR 2 and CD14 mediate innate immunity and lung inflammation to staphylococcal Panton-Valentine leukocidin in vivo. J Immunol 186:1608–1617 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.043513-0
Loading
Current concepts on the virulence mechanisms of meticillin-resistant Staphylococcus aureus
J. Med. Microbiol. 61, 1179 (2012); https://doi.org/10.1099/jmm.0.043513-0
/content/journal/jmm/10.1099/jmm.0.043513-0
/content/journal/jmm/10.1099/jmm.0.043513-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error